Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 1999;54:380-383; doi:10.1136/thx.54.5.380
Copyright © 1999 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 1999;54:380-383 ( May )

Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis

Kevin McCaffery,* a Richard E Olver,a Margaret Franklin,b Somnath Mukhopadhyaya

a Department of Child Health, b Medical Library, c University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK

Correspondence to: Dr S Mukhopadhyay.

Received 28 September 1998; Returned to authors 28 October 1998; Revised version received 9 November 1998; Accepted for publication 11 November 1998

BACKGROUND---The respiratory tract in patients with cystic fibrosis is frequently colonised with Staphylococcus aureus. There is great diversity of clinical practice in this area of cystic fibrosis. A systematic review was conducted to study the evidence relating antistaphylococcal therapy to clinical outcome in patients with cystic fibrosis.
METHODS---A search strategy already evaluated for the study of the epidemiology of cystic fibrosis clinical trials was used. This yielded 3188 references from which 13 clinical trials of antistaphylococcal therapy were identified.
RESULTS---Substantial heterogeneity was observed between trials. In the 13 clinical trials a total of 19 antibiotics were used to assess a wide variety of outcome measures (11 clinical, six laboratory). Both intermittent and continuous treatment strategies were used. Sputum clearance of S aureus was more frequently achieved than any other beneficial outcome. A beneficial effect on pulmonary function was rarely measured or observed. Although five randomised clinical trials were identified, the extent of heterogeneity precluded the use of meta-analysis for further synthesis of information.
CONCLUSIONS---Antistaphylococcal treatment achieves sputum clearance of S aureus in patients with cystic fibrosis. Prophylactic antistaphylococcal treatment in young children with cystic fibrosis is likely to be of clinical benefit. It remains to be determined whether the use of "prophylactic" versus "intermittent" antistaphylococcal therapy in cystic fibrosis is associated with improved lung function and/or chest radiographic scores, an increase in bacterial resistance, or earlier acquisition of Pseudomonas aeruginosa. A large randomised clinical trial lasting approximately two years is urgently required to address this problem.


Keywords: cystic fibrosis; Staphylococcus aureus; systematic review


* Current address: Department of Child Health, University of Glasgow, Royal Hospital for Sick Children, Glasgow, UK.


© 1999 by Thorax

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Elizur, A., Orscheln, R. C., Ferkol, T. W., Atkinson, J. J., Dunne, W. M. Jr, Buller, R. S., Armstrong, J. R., Mardis, E. R., Storch, G. A., Cannon, C. L. (2007). Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Lung Infection in Patients With Cystic Fibrosis. Chest 131: 1718-1725 [Abstract] [Full Text]  
  • Leibovici, L., Soares-Weiser, K., Paul, M., Goldberg, E., Herxheimer, A., Garner, P. (2003). Considering resistance in systematic reviews of antibiotic treatment. J Antimicrob Chemother 52: 564-571 [Abstract] [Full Text]  
  • Lyczak, J. B., Cannon, C. L., Pier, G. B. (2002). Lung Infections Associated with Cystic Fibrosis. Clin. Microbiol. Rev. 15: 194-222 [Abstract] [Full Text]  
  • Doull, I. J M (2001). Recent advances: Recent advances in cystic fibrosis. Arch. Dis. Child. 85: 62-66 [Abstract] [Full Text]  
  • Robinson, C. A., Kuhn, R. J. (2001). Management of Pulmonary Disease in Patients with Cystic Fibrosis. Journal of Pharmacy Practice 14: 207-227 [Abstract]  
  • Pier, G. B. (2000). Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. USA 97: 8822-8828 [Abstract] [Full Text]  
  • SMYTH, A., WALTERS, S., SMYTH;, R., MCCAFFERY, K., OLVER, R. E, FRANKLIN, M., MUKHOPADHYAY, S. (2000). Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis. Thorax 55: 251-251 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs